Veradermics, Inc. (MANE)
104.70
-0.62
(-0.59%)
USD |
NYSE |
May 21, 16:00
104.45
-0.25
(-0.24%)
Pre-Market: 19:59
Veradermics Research and Development Expense (TTM) : 55.51M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Organon & Co. | 363.00M |
| Merck & Co., Inc. | 21.57B |
| Bristol Myers Squibb Co. | 9.494B |
| Terns Pharmaceuticals, Inc. (DELISTED) | 77.89M |
| Corcept Therapeutics, Inc. | 260.44M |